Medical R&D news, white papers, reports, and events from PharmaLeaders. New content daily, on our website and delivered right to your inbox.
Azar demands price transparency, but how will he achieve it? HHS Secretary Alex Azar has thrown down a passionate—and personal—challenge to healthcare providers and drugmakers, demanding they tell patients what a service or product will cost before they receive it. “Especially if we want to move to a system where we put patients more in charge of their own healthcare dollars, providers and insurers have to ... Read More
Indictment: Man used nonprofit to cheat Medicare out of $1M Federal prosecutors say a New Jersey man used a purported not-for-profit group to defraud Medicare out of more than $1 million by convincing hundreds of senior citizens to submit to unnecessary genetic testing. Seth Rehfuss faces two conspiracy counts in the indictment handed up Friday. It’s not known if he’s retains an attorney. Prosecutors say the 43-year-old ... Read More
National Association of Psychiatric Health Systems rebrands amid opioid epidemic The National of Psychiatric Health Systems is undergoing a rebranding to reflect a broadening of the organization’s scope as it addresses the challenges of the ongoing opioid epidemic, and identifies further opportunities for the integration of behavioral and physical healthcare. The not-for-profit Washington D.C.-based advocacy group, which lobbies for the country’s largest psychiatric healthcare providers, has ... Read More
Voting begins for 50 Most Influential Physician Executives and Leaders Voting is underway for Modern Healthcare’s annual ranking of the 50 Most Influential Physician Executives and Leaders. You can cast your vote for one of the 150 nominees on the final ballot, representing high-achieving physician leaders from all sectors of the industry. Voting will be open through the end of day April 10. To cast your ... Read More
Pediatric Gene Therapy The European approvals of Glybera® in 2012 and Strimvelis® in 2016 seem likely to be the vanguard of the therapeutic revolution heralded by the decoding of the human genome. Both of these treatments originated from academic centers of excellence and became the subjects of agreements with pharmaceutical companies (Uniqure/Chiesi and GSK, respectively) with the experience ... Read More
The Case for Intelligent Design (and Infrastructure) in Life Science Biologics R&D New White Paper from IDC Health Insights examines industry trends, new challenges and emerging capabilities in biologics. With many recent blockbuster patents expiring, the pharmaceutical industry finds itself in the middle of a transformation. Leading life science organizations are updating their business strategies to include the pursuit of a new market opportunity – the discovery and development ... Read More